Latest News - James Phillipps
Asset Management Study: how far will the FCA go?
This time tomorrow fund firms will bosses will be picking up the Financial Conduct Authority’s (FCA) final report of its Asset Management Market
Ex-Gun N’ Roses manager’s trust signs up Nile Rodgers
Hipgnosis Songs, the music royalties trust being set up by the former manager of Guns N’ Roses, has signed up funk legend Nile Rodgers to its advisory board.
CEO departs wealth boutique after just two months
Beaufort Investment Management chief executive officer Stewart Murray has left the company, just over two months after being promoted to the role.
The trials and tribulations of living through M&A
Plenty is written about the impact of the frequent merger and acquisition activity in wealth management on clients, but what about the staff involved?
Watchdog gives Standard Life/Aberdeen merger green light
The Competition and Markets Authority (CMA) has given the merger of Standard Life and Aberdeen Asset Management the green light.
Bonham Carter-backed robo taps titans for more cash
The company will look to raise an unspecified amount from both new and existing shareholders.
Signia Wealth names new CIO, with de Merlis to exit
Signia Wealth has named Michael Rosenthal as its new chief investment officer, with the previous incumbent Etienne de Merlis set to leave the company.
LGIM’s Helena Morrissey made a dame in Honours list
Hargreaves Lansdown co-founder Stephen Lansdown has also been awarded the CBE for services in business and the community in Bristol.
John Newlands leaves Brewin to focus on consultancy
John Newlands, Brewin Dolphin’s veteran head of investment companies research, is retiring after nearly a decade at the firm
Asian giant unleashes Japan fund in the UK
Asian fund giant Asset Management One International is to open a multi-cap Japanese equity fund as part of a string of launches designed to build its presence in Europe.
IBT's Craig on the Trump impact for biotech
Ailsa Craig of the International Biotechnology trust highlights the M&A activity seen in the biotechnology sector this year.
Why this ex-UBS private banker blew the whistle
Bradley Birkenfeld discusses the importance of whistle blowers to society and shares his past experiences with UBS.
The time has come for innovative fund fees
With the FCA study around the corner, Orbis director Dan Brocklebank takes a look at how firms could alter their fee structures to improve the industry's reputation.
How should research be priced in a post-Mifid II world?
Being Mifid II-ready has become a competitive advantage which will set firms apart, according to Brij Malkan from BCA research.